MoneyWorks4Me

Bliss GVS Pharma - Quaterly Results

24 Jul 2024 Evaluate
The sales figure stood at Rs. 1489.63 millions for the June 2024 quarter. The mentioned figure indicates a growth of about 36.67% as compared to Rs. 1089.92 millions during the year-ago period.Net Profit witnessed a 159.08% growth almost the double from Rs. 74.96 millions to Rs. 194.21  millions  of same quarter last year.Operating profit for the quarter ended June 2024 rose to 335.83 millions as compared to 175.78 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1489.63 1089.92 36.67 1489.63 1089.92 36.67 6054.60 5983.40 1.19
Other Income 68.41 65.27 4.81 68.41 65.27 4.81 335.01 507.66 -34.01
PBIDT 335.83 175.78 91.05 335.83 175.78 91.05 1406.68 1409.21 -0.18
Interest 11.68 13.09 -10.77 11.68 13.09 -10.77 58.06 100.56 -42.26
PBDT 324.15 162.69 99.24 324.15 162.69 99.24 937.76 1308.65 -28.34
Depreciation 62.61 53.64 16.72 62.61 53.64 16.72 235.19 151.73 55.01
PBT 261.54 109.05 139.83 261.54 109.05 139.83 702.57 1156.92 -39.27
TAX 67.33 34.09 97.51 67.33 34.09 97.51 196.13 302.14 -35.09
Deferred Tax -2.95 7.00 -142.14 -2.95 7.00 -142.14 -75.49 -42.10 79.31
PAT 194.21 74.96 159.08 194.21 74.96 159.08 506.44 854.78 -40.75
Equity 104.88 104.22 0.63 104.88 104.22 0.63 104.69 104.15 0.52
PBIDTM(%) 22.54 16.13 39.79 22.54 16.13 39.79 23.23 23.55 -1.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..